| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 132.981 | 175.702 | 192.665 | 255.222 | 541.771 | 649.893 | 995.063 | 1.330.538 | 1.436.571 | 1.832.844 |
| Total Income - EUR | 142.144 | 315.243 | 192.798 | 255.224 | 541.771 | 655.621 | 995.221 | 1.330.539 | 1.436.580 | 1.832.845 |
| Total Expenses - EUR | 136.054 | 315.019 | 136.355 | 197.184 | 442.295 | 527.778 | 831.476 | 866.730 | 1.027.619 | 1.262.625 |
| Gross Profit/Loss - EUR | 6.090 | 225 | 56.443 | 58.040 | 99.476 | 127.843 | 163.745 | 463.809 | 408.961 | 570.220 |
| Net Profit/Loss - EUR | 4.870 | 161 | 53.872 | 55.488 | 94.899 | 122.196 | 155.518 | 453.066 | 346.087 | 491.903 |
| Employees | 3 | 4 | 4 | 4 | 8 | 10 | 9 | 10 | 14 | 16 |
Check the financial reports for the company - Dermavision Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 257.263 | 43.802 | 10.058 | 34.564 | 29.806 | 52.199 | 300.940 | 326.082 | 274.377 | 503.136 |
| Current Assets | 33.293 | 40.208 | 50.313 | 55.801 | 107.050 | 211.428 | 30.800 | 204.247 | 335.749 | 822.660 |
| Inventories | 25.138 | 32.934 | 25.635 | 28.435 | 48.027 | 56.831 | 20.245 | 2.417 | 218.493 | 233.298 |
| Receivables | 3.170 | 5.792 | 124 | 8.354 | 33.477 | 12.185 | 9.395 | 193.642 | 117.256 | 342.093 |
| Cash | 4.984 | 1.482 | 24.554 | 19.013 | 25.546 | 142.411 | 1.160 | 8.188 | 0 | 247.269 |
| Shareholders Funds | 24.556 | 216 | 52.075 | 55.541 | 95.354 | 193.361 | 222.247 | 453.116 | 539.150 | 491.953 |
| Social Capital | 45 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 281.944 | 83.879 | 8.297 | 34.980 | 41.577 | 70.299 | 109.526 | 76.300 | 68.449 | 833.843 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 913 | 2.527 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermavision Srl